Travere Therapeutics Investor Relations Material
Latest events
Q2 2025
Travere Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Travere Therapeutics Inc
Access all reports
Travere Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases. The company’s research and commercial efforts target conditions related to nephrology, hepatology, and metabolic disorders. It serves patients through both approved treatments and investigational programs. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Travere Therapeutics Inc
Corporate Presentation
Travere Therapeutics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Travere Therapeutics Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TVTX
Country
🇺🇸 United States